Global Anti-Viral Drugs Market Size, Status and Forecast 2025

February 2018 | 91 pages | ID: G042C9791CBEN
QYResearch

Abstracts

This report studies the global Anti-Viral Drugs market, analyzes and researches the Anti-Viral Drugs development status and forecast in United States, EU, Japan, China, India and Southeast Asia.
This report focuses on the top players in global market, like

• Roche
• Gilead
• GlaxoSmithKline
• Bristol-Myers-Squibb
• Abbott
• AstraZeneca
• Cipla
• Schering-PlougH
• Johnson & Johnson
• Merck & Co

Market segment by Regions/Countries, this report covers

• United States
• EU
• Japan
• China
• India
• Southeast Asia

Market segment by Type, the product can be split into

• Nucleotide Polymerase Inhibitors
• Reverse Transcriptase Inhibitors
• Protease Inhibitors

Market segment by Application, Anti-Viral Drugs can be split into

• HIV
• Hepatitis
• Herpes Simplex Virus
• Influenza
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Anti-Viral Drugs Market Size, Status and Forecast 2025

1 INDUSTRY OVERVIEW OF ANTI-VIRAL DRUGS

1.1 Anti-Viral Drugs Market Overview
  1.1.1 Anti-Viral Drugs Product Scope
  1.1.2 Market Status and Outlook
1.2 Global Anti-Viral Drugs Market Size and Analysis by Regions (2013-2018)
  1.2.1 United States
  1.2.2 EU
  1.2.3 Japan
  1.2.4 China
  1.2.5 India
  1.2.6 Southeast Asia
1.3 Anti-Viral Drugs Market by Type
  1.3.1 Nucleotide Polymerase Inhibitors
  1.3.2 Reverse Transcriptase Inhibitors
  1.3.3 Protease Inhibitors
1.4 Anti-Viral Drugs Market by End Users/Application
  1.4.1 HIV
  1.4.2 Hepatitis
  1.4.3 Herpes Simplex Virus
  1.4.4 Influenza
  1.4.5 Other

2 GLOBAL ANTI-VIRAL DRUGS COMPETITION ANALYSIS BY PLAYERS

2.1 Anti-Viral Drugs Market Size (Value) by Players (2013-2018)
2.2 Competitive Status and Trend
  2.2.1 Market Concentration Rate
  2.2.2 Product/Service Differences
  2.2.3 New Entrants
  2.2.4 The Technology Trends in Future

3 COMPANY (TOP PLAYERS) PROFILES

3.1 Roche
  3.1.1 Company Profile
  3.1.2 Main Business/Business Overview
  3.1.3 Products, Services and Solutions
  3.1.4 Anti-Viral Drugs Revenue (Million USD) (2013-2018)
  3.1.5 Recent Developments
3.2 Gilead
  3.2.1 Company Profile
  3.2.2 Main Business/Business Overview
  3.2.3 Products, Services and Solutions
  3.2.4 Anti-Viral Drugs Revenue (Million USD) (2013-2018)
  3.2.5 Recent Developments
3.3 GlaxoSmithKline
  3.3.1 Company Profile
  3.3.2 Main Business/Business Overview
  3.3.3 Products, Services and Solutions
  3.3.4 Anti-Viral Drugs Revenue (Million USD) (2013-2018)
  3.3.5 Recent Developments
3.4 Bristol-Myers-Squibb
  3.4.1 Company Profile
  3.4.2 Main Business/Business Overview
  3.4.3 Products, Services and Solutions
  3.4.4 Anti-Viral Drugs Revenue (Million USD) (2013-2018)
  3.4.5 Recent Developments
3.5 Abbott
  3.5.1 Company Profile
  3.5.2 Main Business/Business Overview
  3.5.3 Products, Services and Solutions
  3.5.4 Anti-Viral Drugs Revenue (Million USD) (2013-2018)
  3.5.5 Recent Developments
3.6 AstraZeneca
  3.6.1 Company Profile
  3.6.2 Main Business/Business Overview
  3.6.3 Products, Services and Solutions
  3.6.4 Anti-Viral Drugs Revenue (Million USD) (2013-2018)
  3.6.5 Recent Developments
3.7 Cipla
  3.7.1 Company Profile
  3.7.2 Main Business/Business Overview
  3.7.3 Products, Services and Solutions
  3.7.4 Anti-Viral Drugs Revenue (Million USD) (2013-2018)
  3.7.5 Recent Developments
3.8 Schering-PlougH
  3.8.1 Company Profile
  3.8.2 Main Business/Business Overview
  3.8.3 Products, Services and Solutions
  3.8.4 Anti-Viral Drugs Revenue (Million USD) (2013-2018)
  3.8.5 Recent Developments
3.9 Johnson & Johnson
  3.9.1 Company Profile
  3.9.2 Main Business/Business Overview
  3.9.3 Products, Services and Solutions
  3.9.4 Anti-Viral Drugs Revenue (Million USD) (2013-2018)
  3.9.5 Recent Developments
3.10 Merck & Co
  3.10.1 Company Profile
  3.10.2 Main Business/Business Overview
  3.10.3 Products, Services and Solutions
  3.10.4 Anti-Viral Drugs Revenue (Million USD) (2013-2018)
  3.10.5 Recent Developments

4 GLOBAL ANTI-VIRAL DRUGS MARKET SIZE BY TYPE AND APPLICATION (2013-2018)

4.1 Global Anti-Viral Drugs Market Size by Type (2013-2018)
4.2 Global Anti-Viral Drugs Market Size by Application (2013-2018)
4.3 Potential Application of Anti-Viral Drugs in Future
4.4 Top Consumer/End Users of Anti-Viral Drugs

5 UNITED STATES ANTI-VIRAL DRUGS DEVELOPMENT STATUS AND OUTLOOK

5.1 United States Anti-Viral Drugs Market Size (2013-2018)
5.2 United States Anti-Viral Drugs Market Size and Market Share by Players (2013-2018)
5.3 United States Anti-Viral Drugs Market Size by Application (2013-2018)

6 EU ANTI-VIRAL DRUGS DEVELOPMENT STATUS AND OUTLOOK

6.1 EU Anti-Viral Drugs Market Size (2013-2018)
6.2 EU Anti-Viral Drugs Market Size and Market Share by Players (2013-2018)
6.3 EU Anti-Viral Drugs Market Size by Application (2013-2018)

7 JAPAN ANTI-VIRAL DRUGS DEVELOPMENT STATUS AND OUTLOOK

7.1 Japan Anti-Viral Drugs Market Size (2013-2018)
7.2 Japan Anti-Viral Drugs Market Size and Market Share by Players (2013-2018)
7.3 Japan Anti-Viral Drugs Market Size by Application (2013-2018)

8 CHINA ANTI-VIRAL DRUGS DEVELOPMENT STATUS AND OUTLOOK

8.1 China Anti-Viral Drugs Market Size (2013-2018)
8.2 China Anti-Viral Drugs Market Size and Market Share by Players (2013-2018)
8.3 China Anti-Viral Drugs Market Size by Application (2013-2018)

9 INDIA ANTI-VIRAL DRUGS DEVELOPMENT STATUS AND OUTLOOK

9.1 India Anti-Viral Drugs Market Size (2013-2018)
9.2 India Anti-Viral Drugs Market Size and Market Share by Players (2013-2018)
9.3 India Anti-Viral Drugs Market Size by Application (2013-2018)

10 SOUTHEAST ASIA ANTI-VIRAL DRUGS DEVELOPMENT STATUS AND OUTLOOK

10.1 Southeast Asia Anti-Viral Drugs Market Size (2013-2018)
10.2 Southeast Asia Anti-Viral Drugs Market Size and Market Share by Players (2013-2018)
10.3 Southeast Asia Anti-Viral Drugs Market Size by Application (2013-2018)

11 MARKET FORECAST BY REGIONS, TYPE AND APPLICATION (2018-2025)

11.1 Global Anti-Viral Drugs Market Size (Value) by Regions (2018-2025)
  11.1.1 United States Anti-Viral Drugs Revenue and Growth Rate (2018-2025)
  11.1.2 EU Anti-Viral Drugs Revenue and Growth Rate (2018-2025)
  11.1.3 Japan Anti-Viral Drugs Revenue and Growth Rate (2018-2025)
  11.1.4 China Anti-Viral Drugs Revenue and Growth Rate (2018-2025)
  11.1.5 India Anti-Viral Drugs Revenue and Growth Rate (2018-2025)
  11.1.6 Southeast Asia Anti-Viral Drugs Revenue and Growth Rate (2018-2025)
11.2 Global Anti-Viral Drugs Market Size (Value) by Type (2018-2025)
11.3 Global Anti-Viral Drugs Market Size by Application (2018-2025)

12 ANTI-VIRAL DRUGS MARKET DYNAMICS

12.1 Anti-Viral Drugs Market Opportunities
12.2 Anti-Viral Drugs Challenge and Risk
  12.2.1 Competition from Opponents
  12.2.2 Downside Risks of Economy
12.3 Anti-Viral Drugs Market Constraints and Threat
  12.3.1 Threat from Substitute
  12.3.2 Government Policy
  12.3.3 Technology Risks
12.4 Anti-Viral Drugs Market Driving Force
  12.4.1 Growing Demand from Emerging Markets
  12.4.2 Potential Application

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
  13.3.1 Economic Fluctuations
  13.3.2 Other Risk Factors

14 RESEARCH FINDING/CONCLUSION

15 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Global Anti-Viral Drugs Market Size (Million USD) Status and Outlook (2013-2018)
Table Global Anti-Viral Drugs Revenue (Million USD) Comparison by Regions (2013-2018)
Figure Global Anti-Viral Drugs Market Share by Regions (2013-2018)
Figure United States Anti-Viral Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure EU Anti-Viral Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure Japan Anti-Viral Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure China Anti-Viral Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure India Anti-Viral Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure Southeast Asia Anti-Viral Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Table Global Anti-Viral Drugs Revenue (Million USD) and Growth Rate (%) Comparison by Product (2013-2018)
Figure Global Anti-Viral Drugs Revenue Market Share by Type in 2017
Figure Nucleotide Polymerase Inhibitors Market Size (Million USD) and Growth Rate (2013-2018)
Figure Reverse Transcriptase Inhibitors Market Size (Million USD) and Growth Rate (2013-2018)
Figure Protease Inhibitors Market Size (Million USD) and Growth Rate (2013-2018)
Figure Global Anti-Viral Drugs Market Share by Application in 2017
Figure Anti-Viral Drugs Market Size (Million USD) and Growth Rate in HIV (2013-2018)
Figure Anti-Viral Drugs Market Size (Million USD) and Growth Rate in Hepatitis (2013-2018)
Figure Anti-Viral Drugs Market Size (Million USD) and Growth Rate in Herpes Simplex Virus (2013-2018)
Figure Anti-Viral Drugs Market Size (Million USD) and Growth Rate in Influenza (2013-2018)
Figure Anti-Viral Drugs Market Size (Million USD) and Growth Rate in Other (2013-2018)
Table Anti-Viral Drugs Market Size (Million USD) by Players (2013-2018)
Figure Anti-Viral Drugs Market Size Share by Players in 2013
Figure Anti-Viral Drugs Market Size Share by Players in 2017
Table Roche Basic Information List
Table Anti-Viral Drugs Business Revenue (Million USD) of Roche (2013-2018)
Figure Roche Anti-Viral Drugs Business Revenue Market Share (2013-2018)
Table Gilead Basic Information List
Table Anti-Viral Drugs Business Revenue (Million USD) of Gilead (2013-2018)
Figure Gilead Anti-Viral Drugs Business Revenue Market Share (2013-2018)
Table GlaxoSmithKline Basic Information List
Table Anti-Viral Drugs Business Revenue (Million USD) of GlaxoSmithKline (2013-2018)
Figure GlaxoSmithKline Anti-Viral Drugs Business Revenue Market Share (2013-2018)
Table Bristol-Myers-Squibb Basic Information List
Table Anti-Viral Drugs Business Revenue (Million USD) of Bristol-Myers-Squibb (2013-2018)
Figure Bristol-Myers-Squibb Anti-Viral Drugs Business Revenue Market Share (2013-2018)
Table Abbott Basic Information List
Table Anti-Viral Drugs Business Revenue (Million USD) of Abbott (2013-2018)
Figure Abbott Anti-Viral Drugs Business Revenue Market Share (2013-2018)
Table AstraZeneca Basic Information List
Table Anti-Viral Drugs Business Revenue (Million USD) of AstraZeneca (2013-2018)
Figure AstraZeneca Anti-Viral Drugs Business Revenue Market Share (2013-2018)
Table Cipla Basic Information List
Table Anti-Viral Drugs Business Revenue (Million USD) of Cipla (2013-2018)
Figure Cipla Anti-Viral Drugs Business Revenue Market Share (2013-2018)
Table Schering-PlougH Basic Information List
Table Anti-Viral Drugs Business Revenue (Million USD) of Schering-PlougH (2013-2018)
Figure Schering-PlougH Anti-Viral Drugs Business Revenue Market Share (2013-2018)
Table Johnson & Johnson Basic Information List
Table Anti-Viral Drugs Business Revenue (Million USD) of Johnson & Johnson (2013-2018)
Figure Johnson & Johnson Anti-Viral Drugs Business Revenue Market Share (2013-2018)
Table Merck & Co Basic Information List
Table Anti-Viral Drugs Business Revenue (Million USD) of Merck & Co (2013-2018)
Figure Merck & Co Anti-Viral Drugs Business Revenue Market Share (2013-2018)
Table Global Anti-Viral Drugs Market Size (Million USD) by Product (2013-2018)
Figure Global Anti-Viral Drugs Revenue Market Share (%) by Product (2013-2018)
Figure Global Anti-Viral Drugs Market Share by Product in 2017
Table Global Anti-Viral Drugs Market Size by Application (2013-2018)
Figure Global Anti-Viral Drugs Revenue Market Share (%) by Application in 2017
Table Top Consumer/End Users of Anti-Viral Drugs
Figure United States Anti-Viral Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table United States Anti-Viral Drugs Market Size (Million USD) by Players (2013-2018)
Figure United States Anti-Viral Drugs Market Size Share by Players in 2013
Figure United States Anti-Viral Drugs Market Size Share by Players in 2017
Table United States Anti-Viral Drugs Market Size by Application (2013-2018)
Figure United States Anti-Viral Drugs Revenue Market Share (%) by Application (2013-2018)
Figure United States Anti-Viral Drugs Market Size Share by Application in 2017
Figure EU Anti-Viral Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table EU Anti-Viral Drugs Market Size (Million USD) by Players (2013-2018)
Figure EU Anti-Viral Drugs Market Size Share by Players in 2013
Figure EU Anti-Viral Drugs Market Size Share by Players in 2017
Table EU Anti-Viral Drugs Market Size by Application (2013-2018)
Figure EU Anti-Viral Drugs Revenue Market Share (%) by Application (2013-2018)
Figure EU Anti-Viral Drugs Market Size Share by Application in 2017
Figure Japan Anti-Viral Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table Japan Anti-Viral Drugs Market Size (Million USD) by Players (2013-2018)
Figure Japan Anti-Viral Drugs Market Size Share by Players in 2013
Figure Japan Anti-Viral Drugs Market Size Share by Players in 2017
Table Japan Anti-Viral Drugs Market Size by Application (2013-2018)
Figure Japan Anti-Viral Drugs Revenue Market Share (%) by Application (2013-2018)
Figure Japan Anti-Viral Drugs Market Size Share by Application in 2017
Figure China Anti-Viral Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table China Anti-Viral Drugs Market Size (Million USD) by Players (2013-2018)
Figure China Anti-Viral Drugs Market Size Share by Players in 2013
Figure China Anti-Viral Drugs Market Size Share by Players in 2017
Table China Anti-Viral Drugs Market Size by Application (2013-2018)
Figure China Anti-Viral Drugs Revenue Market Share (%) by Application (2013-2018)
Figure China Anti-Viral Drugs Market Size Share by Application in 2017
Figure India Anti-Viral Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table India Anti-Viral Drugs Market Size (Million USD) by Players (2013-2018)
Figure India Anti-Viral Drugs Market Size Share by Players in 2013
Figure India Anti-Viral Drugs Market Size Share by Players in 2017
Table India Anti-Viral Drugs Market Size by Application (2013-2018)
Figure India Anti-Viral Drugs Revenue Market Share (%) by Application (2013-2018)
Figure India Anti-Viral Drugs Market Size Share by Application in 2017
Figure Southeast Asia Anti-Viral Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table Southeast Asia Anti-Viral Drugs Market Size (Million USD) by Players (2013-2018)
Figure Southeast Asia Anti-Viral Drugs Market Size Share by Players in 2013
Figure Southeast Asia Anti-Viral Drugs Market Size Share by Players in 2017
Table Southeast Asia Anti-Viral Drugs Market Size by Application (2013-2018)
Figure Southeast Asia Anti-Viral Drugs Revenue Market Share (%) by Application (2013-2018)
Figure Southeast Asia Anti-Viral Drugs Market Size Share by Application in 2017
Figure Global Anti-Viral Drugs Market Size and Growth Rate (2018-2025)
Table Global Anti-Viral Drugs Market Size (Million USD) by Regions (2018-2025)
Figure Global Anti-Viral Drugs Market Size Share (2018-2025)
Figure Global Anti-Viral Drugs Market Size Share by Regions in 2025
Figure United States Anti-Viral Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Figure EU Anti-Viral Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Figure Japan Anti-Viral Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Figure China Anti-Viral Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Figure India Anti-Viral Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Figure Southeast Asia Anti-Viral Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Table Global Anti-Viral Drugs Market Size (Million USD) by Type (2018-2025)
Figure Global Anti-Viral Drugs Market Size Share by Type in 2018
Figure Global Anti-Viral Drugs Market Size Share by Type in 2025
Table Global Anti-Viral Drugs Market Size (Million USD) by Application (2018-2025)
Figure Global Anti-Viral Drugs Market Size (Million USD) by Application in 2018
Figure Global Anti-Viral Drugs Market Size (Million USD) by Application in 2025